Stanford University
Showing 341-350 of 615 Results
-
Juan Sebastián Gómez-Cañón
Postdoctoral Scholar, Psychiatry
BioJuan S. Gómez-Cañón is a researcher, engineer and musician from Colombia. He holds a Ph.D. in Information and Communication Technologies from the Universitat Pompeu Fabra (Barcelona, Spain). During his Ph.D., Juan researched human-centered and trustworthy machine learning methods to predict the emotions in music. His research focuses on deep learning, human-centered ML, personalization, dataset curation, and digital signal processing. Juan also holds a M.Sc. in Media Technology (Technische Universität Ilmenau, Germany), a B.Sc. in Electronics Engineering and a B.A. in Music (Universidad de los Andes, Colombia).
-
Natalia Gomez-Ospina
Assistant Professor of Pediatrics (Genetics)
Current Research and Scholarly InterestsDr. Gomez-Ospina is a physician scientist and medical geneticist with a strong interest in the diagnosis and management of genetic diseases.
1) Lysosomal storage diseases:
Her research program is on developing better therapies for a large class of neurodegenerative diseases in children known as lysosomal storage disorders. Her current focus is on developing genome editing of hematopoietic stem cells as a therapeutic approach for these diseases beginning with Mucopolysaccharidosis type 1 and Gaucher disease. She established a genetic approach where therapeutic proteins can be targeted to a single well-characterized place in the genome known as a safe harbor. This approach constitutes a flexible, “one size fits all” approach that is independent of specific genes and mutations. This strategy, in which the hematopoietic system is commandeered to express and deliver therapeutic proteins to the brain can potentially change the current approaches to treating childhood neurodegenerative diseases and pave the way for alternative therapies for adult neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease
2) Point of care ammonia testing
She also works in collaboration with other researchers at Stanford to develop point-of-care testing for serum ammonia levels. Such device will greatly improve the quality of life of children and families with metabolic disorders with hyperammonemia.
3) Gene discovery
Dr Gomez-Ospina lead a multi-institutional collaboration resulting in the discovery of a novel genetic cause of neonatal and infantile cholestatic liver disease. She collaborated in the description of two novel neurologic syndromes caused by mutations in DYRK1 and CHD4.
For more information go to our website:
https://www.gomezospina.com/ -
Li Gong
Scientific Data Curator 3, Biomedical Data Science
Current Role at StanfordProgram manager and senior scientific curator for ClinPGx, coordinator for the ClinGen Pharmacogenomics Interpretation Committee (PGxIC).
